Predictors of non-adherence to antihypertensive medications: A cross-sectional study from a regional hospital in Afghanistan

PLoS One. 2023 Dec 27;18(12):e0295246. doi: 10.1371/journal.pone.0295246. eCollection 2023.

Abstract

Background: Non-adherence to antihypertensive medications (AHMs) is a widespread problem. Cardiovascular morbidity and mortality reduction is possible via better adherence rates among hypertensive patients.

Objectives: This study aimed to assess the prevalence of non-adherence to AHMs and its predictors among hypertensive patients who attended Mirwais Regional Hospital in Kandahar, Afghanistan.

Methods: A cross-sectional study using random sampling method was conducted among hypertensive patients, aged ≥18 years in Mirwais Regional Hospital at a 6-month follow-up between October and December 2022. To assess non-adherence to AHMs, we employed the Hill-Bone Medication Adherence scale. A value below or equal to 80% of the total score was used to signify non-adherence. A multivariable binary logistic regression model was used to identify predictors of non-adherence to AHMs.

Results: We used data from 669 patients and found that 47.9% (95%CI: 44.1-51.8%) of them were non-adherent to AHMs. The majority (71.2%) of patients had poorly controlled blood pressure (BP). The likelihood of non-adherence to AHMs was significantly higher among patients from low monthly-income households [Adjusted odds ratio (AOR) 1.70 (95%CI: 1.13-2.55)], those with daily intake of multiple AHMs [AOR 2.02 (1.29-3.16)], presence of comorbid medical conditions [AOR 1.68 (1.05-2.67), lack of awareness of hypertension-related complications [AOR 2.40 (1.59-3.63)], and presence of depressive symptoms [AOR 1.65 (1.14-2.38)].

Conclusion: Non-adherence to AHMs was high. Non-adherence to AHMs is a potential risk factor for uncontrolled hypertension and subsequent cardiovascular complications. Policymakers and clinicians should implement evidence-based interventions to address factors undermining AHMs adherence in Afghanistan.

MeSH terms

  • Adolescent
  • Adult
  • Afghanistan / epidemiology
  • Antihypertensive Agents* / therapeutic use
  • Cross-Sectional Studies
  • Hospitals
  • Humans
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Medication Adherence

Substances

  • Antihypertensive Agents

Grants and funding

This study was financially supported by the Excellent Center for Dengue and Community Public Health, School of Public Health [WU-COE-66-16], and the Walailak University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.